In T-cell acute leukemia (T-ALL) cells, inhibition of the cyclin D3-CDK6 complex resulted in inhibition of phosphofructokinase 1 (PFK1) and PKM2, which redirected glucose metabolites into the PPP and the serine biogenesis pathway [181]. The gene discussed is PFKM; the disease is acute lymphoblastic leukemia.